Our study has assessed new molecular probes for PET/CT using three biomarkers (PSMA, GRPR, and NTR1) with potential for non-invasive stratification of PCa patients and potential for translational application in the clinic. The gene discussed is FOLH1; the disease is posterior cortical atrophy.